<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="169050">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00896142</url>
  </required_header>
  <id_info>
    <org_study_id>0601112</org_study_id>
    <nct_id>NCT00896142</nct_id>
  </id_info>
  <brief_title>Optima Coronary Artery Disease (CAD) (Optimal Mechanical Evaluation)</brief_title>
  <official_title>Optima CAD (Optimal Mechanical Evaluation)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <brief_summary>
    <textblock>
      To evaluate the impact of left ventricular (LV) lead location on LV mechanical function.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Heart Failure</condition>
  <condition>Ischemic Cardiomyopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        18+ years of age must be patients of UPMC Cardiovascular Institute
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Ischemic Cardiomyopathy

          2. Left ventricular ejection fraction less than 40%

          3. Clinical indication for invasive electrophysiology testing

          4. Patient is at least 18 years of age

        Exclusion Criteria

          1. Unstable angina, acute myocardial infarction and/or revascularization procedure
             within 3 months

          2. CVA or TIA within the past 6 months

          3. Prosthetic heart valve

          4. Patient is status post heart transplant

          5. Women who are pregnant or with child -bearing potential and who are not on a reliable
             form of birth control. Women of child-bearing potential are routinely tested for
             pregnancy as part of the standard of care prior to EPS procedures being performed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David S. Schwartzman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPMC Presybterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <lastchanged_date>November 21, 2011</lastchanged_date>
  <firstreceived_date>May 8, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ischemic cardiomyopathy</keyword>
  <keyword>cardiac resynchronization therapy</keyword>
  <keyword>LV structure and function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
